You have successfully logged out.
Skip to main content
Product News, Studies & Articles | GileadPro
Other Languages
Register
Login
About Us
Go Back
About Us
Working in Partnership
Swiss Fellowship Program
Research Support Programs
Therapy Areas
Go Back
Therapy Areas
HIV
Liver
Oncology
COVID-19
Invasive Fungal Disease (IFD)
Products
Go Back
Products
HIV
Liver
Oncology
CAR T
COVID-19
Invasive Fungal Diseases (IFDs)
Events
Go Back
Events
Upcoming Events
Past Events
Resources
Go Back
Resources
Our Clinical Trials
Medical Information
Materials Ordering
Search
Other Languages
Register
Login
Home
Product News, Studies & Articles
Product News, Studies & Articles
Oncology, Hematology & CAR-T
Product News, Studies & Articles
Novel Therapies for Metastatic Triple-Negative Breast Cancer: ...
Mon, 31 May 2021, 12:30 AM
Monday, 31 May 2021 12:30 AM
Triple-negative breast cancer (TNBC) is a biologically heterogeneous disease that is often associated with worse...
ImmunityBio (IBRX) Announces FDA Authorizes its Study of Ankti...
Tue, 15 Jun 2021, 12:30 AM
Tuesday, 15 June 2021 12:30 AM
Open-label Phase 1b/2 study will evaluate the safety and preliminary efficacy of Anktiva (N-803) and PD-L1 t-haN...
Moving Towards Targeted Therapies for Triple-Negative Breast C...
Mon, 07 Jun 2021, 12:30 AM
Monday, 07 June 2021 12:30 AM
In this review, we discuss targets of interest in triple-negative breast cancer (TNBC), approved targeted agents...
Load More
